Viking Therapeutics (VKTX) EPS (Basic) (2014 - 2026)
Viking Therapeutics (VKTX) reported EPS (Basic) of -$2.3 for Q1 2026, down 113.25% on a YoY basis from $17.39 in Q1 2025, and up 6.76% sequentially from -$2.47 in Q4 2025.
Viking Therapeutics (VKTX) EPS (Basic) (2014 - 2026) Analysis & Trends
Viking Therapeutics (VKTX) has 13 years of EPS (Basic) data on file, last reported at -$2.3 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 113.25% year-over-year to -$2.3; the trailing twelve-month figure through Mar 2026 stood at -$7.52 (up 1.47% YoY), and the FY2025 full-year result was -$4.49, down 55.54% from the prior year.
- EPS (Basic) rose to -$2.3 in Q1 2026, from -$2.47 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.23 in Q3 2022 to a low of -$768.41 in Q1 2023.
- A 5-year average of -$89.65 and a median of -$1.74 in 2024 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) sank 314896.78% in 2023 and soared 99.53% in 2024, its largest moves.
- Tracing VKTX's EPS (Basic) over 5 years: stood at -$0.52 in 2022, then sank by 84.18% to -$0.96 in 2023, then slumped by 80.39% to -$1.74 in 2024, then slumped by 42.23% to -$2.47 in 2025, then grew by 6.76% to -$2.3 in 2026.
- Business Quant data shows VKTX's EPS (Basic) at -$2.3 in Q1 2026, -$2.47 in Q4 2025, and -$1.54 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Viking Therapeutics | 4.03 Bn | 4.03 Bn | - | -2.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.30 |
| Dec 31, 2025 | -2.47 |
| Sep 30, 2025 | -1.54 |
| Jun 30, 2025 | -1.35 |
| Mar 31, 2025 | -1.08 |
| Dec 31, 2024 | -1.74 |
| Sep 30, 2024 | -2.59 |
| Jun 30, 2024 | -2.33 |
| Mar 31, 2024 | -4.21 |
| Dec 31, 2023 | -0.96 |
| Sep 30, 2023 | -233.52 |
| Jun 30, 2023 | -500.21 |
| Mar 31, 2023 | -768.41 |
| Dec 31, 2022 | -0.52 |
| Sep 30, 2022 | -0.23 |
| Jun 30, 2022 | -0.25 |
| Mar 31, 2022 | -0.24 |
| Dec 31, 2021 | -0.20 |
| Sep 30, 2021 | -0.24 |
| Jun 30, 2021 | -0.26 |